Kiniksa Pharmaceuticals Ltd (KNSA) financials · rev $677.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Kiniksa Pharmaceuticals Ltd (KNSA) rev $677.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $677.6M | $423.2M |
| Cost of Revenue | $77.7M | $60.9M |
| Gross Profit | $599.9M | $362.3M |
| Operating Income | $77.2M | -$45.6M |
| Net Income | $59.0M | -$43.2M |
| EPS (Diluted) | $0.75 | -$0.60 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $763.6M | $580.6M |
| Current Assets | $527.2M | $331.8M |
| Cash & Equivalents | $165.6M | $183.6M |
| Inventory | $54.9M | $26.4M |
| PP&E | $1.94M | $662.0K |
| Total Liabilities | $196.0M | $142.1M |
| Current Liabilities | $139.2M | $100.6M |
| Shareholders' Equity | $567.6M | $438.4M |
| Retained Earnings | -$462.1M | -$521.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $138.0M | $25.7M |
| CapEx | $1.57M | $277.0K |
| Investing Cash Flow | -$189.0M | $37.7M |
| Financing Cash Flow | $33.0M | $12.3M |
| Free Cash Flow | $136.4M | $25.4M |
FAQ
What is KNSA P/E and revenue?
Kiniksa Pharmaceuticals Ltd (KNSA) rev $677.6M.
What is KNSA revenue?
Kiniksa Pharmaceuticals Ltd last cached revenue is $677.6M (FY2025).
Is KNSA profitable?
Kiniksa Pharmaceuticals Ltd last cached net income is $59.0M (FY2025).
What are KNSA total assets?
Kiniksa Pharmaceuticals Ltd last cached total assets are $763.6M (FY2025).
What is KNSA free cash flow?
Kiniksa Pharmaceuticals Ltd last cached free cash flow is $136.4M (FY2025).
Not investment advice. Cached statements, not a live tape.